The American Foundation for Pharmaceutical Education, or AFPE, announced two UF College of Pharmacy graduate students were selected to receive Pre-Doctoral Research Fellowships in Pharmaceutical Sciences for the upcoming 2023-24 academic year.
Ph.D. candidates Nam Nguyen and Hulin Tang were selected by AFPE for their research that positively impacts public health and patient outcomes. The primary purpose of the AFPE Pre-Doctoral Fellowship Program is to support students who have leadership potential in the pharmaceutical industry, academia and the government.
Nguyen, a fourth-year graduate student under the mentorship of Jatinder Lamba, Ph.D., M.Sc., associate dean for research and graduate education and a professor in the UF College of Pharmacy, researches childhood acute myeloid leukemia, or AML. His research holds the potential to uncover the molecular biology underlying chemoresistance and to discover novel drugs that overcome chemoresistance.
“Our research is important because there is limited research on pediatric AML,” Nguyen said. “This fellowship will only deepen my passion for academia and research and inspire me to pursue a career where I can continue to educate future pharmaceutical leaders.”
Tang, a third-year graduate student in the department of pharmaceutical outcomes and policy, is mentored by Serena Guo, M.D., Ph.D., an assistant professor in the UF College of Pharmacy. Tang investigates the relationship between new diabetes medications and neurodegenerative diseases in type 2 diabetes patients. He is proud of his research and the impact it has on helping individuals with type 2 diabetes who are at high risk for neurodegenerative diseases.
“Such research holds the potential for a significant impact on society by addressing health disparities and enhancing health outcomes,” Tang said.